Creo Medical Group PLC (LON:CREO – Get Free Report) insider Richard John Rees bought 98,000 shares of the company’s stock in a transaction on Thursday, October 24th. The stock was purchased at an average cost of GBX 20 ($0.26) per share, with a total value of £19,600 ($25,447.94).
Creo Medical Group Stock Performance
Shares of CREO stock opened at GBX 20 ($0.26) on Friday. Creo Medical Group PLC has a fifty-two week low of GBX 19 ($0.25) and a fifty-two week high of GBX 50 ($0.65). The company has a 50 day moving average price of GBX 25.91 and a 200 day moving average price of GBX 31.02. The stock has a market capitalization of £72.36 million, a P/E ratio of -333.33 and a beta of 0.86. The company has a debt-to-equity ratio of 29.96, a quick ratio of 2.19 and a current ratio of 3.24.
About Creo Medical Group
Read More
- Five stocks we like better than Creo Medical Group
- How to Most Effectively Use the MarketBeat Earnings Screener
- Texas Roadhouse Stock Steering for New Highs This Year
- Profitably Trade Stocks at 52-Week Highs
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.